M

Director Director DIN 06927804
DIN 06927804 First appointment Aug 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Manu

Data last updated:

Manu was a Director at Chahat Pharma Private Limited (2015–2019) and Director at Canton Pharma Opc Private Limited (from 2014). The companies operate in Pharma.

DIN 06927804
Primary Designation Director
Industry Pharma
First Appointment 06 Aug 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chahat Pharma Private Limited U24233DL2012PTC232389
Director28 May 20152012Active
Canton Pharma Opc Private Limited U85100DL2014OPC270013
Director06 Aug 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Canton Pharma Opc Private Limited
Chahat Pharma Private Limited
Premium access

Shareholding and investment profile for Manu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manu

Manu was first appointed on 06 Aug 2014 as Director at Canton Pharma Opc Private Limited. The most recent appointment on record is 28 May 2015 at Chahat Pharma Private Limited.

Manu held 2 earlier board appointments: Chahat Pharma Private Limited (Director, 28 May 2015 to 26 Mar 2019); Canton Pharma Opc Private Limited (Director, from 06 Aug 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available